AnaCardio
AnaCardio develops oral medicines intended to improve heart muscle contraction in people with heart failure.
€62.5MSeries B
ParticipantI
Industrifonden
industrifonden.com ↗Activity from announced rounds
Activity in this selectionOct 16, 2026 · Sep 17, 2026
Industrifonden is an evergreen venture investor supporting technology and life-science companies in Sweden and the wider Nordic region.
Investment focus
Its long-term capital structure allows investment beyond a fixed fund term. The stated areas include human health, enterprise software and AI, and technologies emerging from science and engineering, with support for businesses scaling internationally.
Activity recorded by RoundOS
RoundOS examples include AnaCardio’s heart-failure therapeutics, Pixelgen’s molecular analysis technology, Trialbee’s clinical-trial recruitment and Soundtrap’s collaborative audio software. They illustrate distinct life-science and software activity in this database, rather than the investor’s full portfolio.
Sources
- Rounds participated in
- 2
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $78.6M 2 disclosed · full round size, not this investor’s share